Quest Diagnostics Inc. Sets New 1-Year Low at $52.11 (DGX)
Quest Diagnostics (NYSE:DGX)’s share price reached a new 52-week low on Friday, Stock Ratings Network.com reports. The company traded as low as $52.11 and last traded at $52.95, with a volume of 4,502,355 shares traded. The stock had previously closed at $52.85.
A number of research firms have recently commented on DGX. Analysts at JMP Securities initiated coverage on shares of Quest Diagnostics in a research note to investors on Wednesday, December 18th. They set a “market perform” rating on the stock. Separately, analysts at Morgan Stanley reiterated an “underweight” rating on shares of Quest Diagnostics in a research note to investors on Thursday, December 12th. They now have a $58.00 price target on the stock. Finally, analysts at Citigroup Inc. reiterated a “neutral” rating on shares of Quest Diagnostics in a research note to investors on Wednesday, December 11th. They now have a $58.00 price target on the stock, down previously from $59.00. Five equities research analysts have rated the stock with a sell rating, fifteen have given a hold rating and four have issued a buy rating to the company’s stock. Quest Diagnostics presently has an average rating of “Hold” and a consensus price target of $59.79.
Quest Diagnostics has a 1-year low of $52.50 and a 1-year high of $64.10. The stock has a 50-day moving average of $57.86 and a 200-day moving average of $59.66. The company has a market cap of $7.667 billion and a P/E ratio of 10.85. Quest Diagnostics also was the target of unusually large options trading on Tuesday. Traders purchased 2,582 put options on the stock. This represents an increase of 252% compared to the typical daily volume of 734 put options.
Quest Diagnostics (NYSE:DGX) last announced its earnings results on Thursday, October 17th. The company reported $1.02 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.20 by $0.18. The company had revenue of $1.79 billion for the quarter, compared to the consensus estimate of $1.84 billion. During the same quarter in the previous year, the company posted $1.18 earnings per share. The company’s revenue for the quarter was down 1.9% on a year-over-year basis.
The company also recently announced a quarterly dividend, which is scheduled for Wednesday, January 22nd. Stockholders of record on Tuesday, January 7th will be paid a dividend of 0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 2.28%. The ex-dividend date is Friday, January 3rd.
Quest Diagnostics Incorporated (NYSE:DGX)is a provider of diagnostic testing, information and services, providing insights that enable patients and physicians to make healthcare decisions.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.